All entries for: Obsidian Therapeutics, Inc.

August 3, 2026

Obsidian Therapeutics, Inc.

Neutral Outlook

Cambridge, MA
51-200 employees

The effect of IRA on our business and the healthcare industry in general is not yet known.

Disease Area: Oncology
Drug Type: Biologic
Scroll to Top